-
1
-
-
1142310583
-
Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A
-
Giese T., Zeier M., Schemmer P., Uhl W., Schoels M., Dengler T., Buechler M., and Meuer S. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation 77 3 (2004) 339-344
-
(2004)
Transplantation
, vol.77
, Issue.3
, pp. 339-344
-
-
Giese, T.1
Zeier, M.2
Schemmer, P.3
Uhl, W.4
Schoels, M.5
Dengler, T.6
Buechler, M.7
Meuer, S.8
-
2
-
-
4344653892
-
Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors
-
Giese T., Zeier M., and Meuer S. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors. Nephrol. Dial Transplant. 19 Suppl 4 (2004) IV55-IV60
-
(2004)
Nephrol. Dial Transplant.
, vol.19
, Issue.SUPPL. 4
-
-
Giese, T.1
Zeier, M.2
Meuer, S.3
-
3
-
-
0034594881
-
Improved graft survival after renal transplantation in the United States, 1988 to 1996
-
Hariharan S., Johnson C.P., Bresnahan B.A., Taranto S.E., McIntosh M.J., and Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 342 9 (2000) 605-612
-
(2000)
N. Engl. J. Med.
, vol.342
, Issue.9
, pp. 605-612
-
-
Hariharan, S.1
Johnson, C.P.2
Bresnahan, B.A.3
Taranto, S.E.4
McIntosh, M.J.5
Stablein, D.6
-
4
-
-
40649117424
-
Cancers after renal transplantation
-
Wong G., and Chapman J.R. Cancers after renal transplantation. Transplant. Rev. (Orlando) 22 2 (2008) 141-149
-
(2008)
Transplant. Rev. (Orlando)
, vol.22
, Issue.2
, pp. 141-149
-
-
Wong, G.1
Chapman, J.R.2
-
5
-
-
67651197536
-
-
2007 OPTN/SRTR Annual Report 1997-2006. HHS/HRSA/HSB/DOT.
-
2007 OPTN/SRTR Annual Report 1997-2006. HHS/HRSA/HSB/DOT.
-
-
-
-
6
-
-
1442338509
-
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era
-
Meier-Kriesche H.U., Schold J.D., Srinivas T.R., and Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4 3 (2004) 378-383
-
(2004)
Am. J. Transplant.
, vol.4
, Issue.3
, pp. 378-383
-
-
Meier-Kriesche, H.U.1
Schold, J.D.2
Srinivas, T.R.3
Kaplan, B.4
-
7
-
-
0037182904
-
The changing causes of graft loss and death after kidney transplantation
-
Howard R.J., Patton P.R., Reed A.I., Hemming A.W., Van der Werf W.J., Pfaff W.W., Srinivas T.R., and Scornik J.C. The changing causes of graft loss and death after kidney transplantation. Transplantation 73 12 (2002) 1923-1928
-
(2002)
Transplantation
, vol.73
, Issue.12
, pp. 1923-1928
-
-
Howard, R.J.1
Patton, P.R.2
Reed, A.I.3
Hemming, A.W.4
Van der Werf, W.J.5
Pfaff, W.W.6
Srinivas, T.R.7
Scornik, J.C.8
-
9
-
-
34250179862
-
Malignancies in renal transplantation: an unmet medical need
-
Dantal J., and Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol. Dial Transplant. 22 Suppl. 1 (2007) i4-i10
-
(2007)
Nephrol. Dial Transplant.
, vol.22
, Issue.SUPPL. 1
-
-
Dantal, J.1
Pohanka, E.2
-
10
-
-
2542504501
-
Malignancy in renal transplantation
-
Morath C., Mueller M., Goldschmidt H., Schwenger V., Opelz G., and Zeier M. Malignancy in renal transplantation. J. Am. Soc. Nephrol. 15 6 (2004) 1582-1588
-
(2004)
J. Am. Soc. Nephrol.
, vol.15
, Issue.6
, pp. 1582-1588
-
-
Morath, C.1
Mueller, M.2
Goldschmidt, H.3
Schwenger, V.4
Opelz, G.5
Zeier, M.6
-
11
-
-
0037337675
-
Tumours after kidney transplantation
-
Lutz J., and Heemann U. Tumours after kidney transplantation. Curr. Opin. Urol. 13 2 (2003) 105-109
-
(2003)
Curr. Opin. Urol.
, vol.13
, Issue.2
, pp. 105-109
-
-
Lutz, J.1
Heemann, U.2
-
12
-
-
0035993741
-
De novo breast cancer in renal transplant recipients
-
Buell J.F., Hanaway M.J., Trofe J., Gross T.G., Beebe T.M., Alloway R.R., First M.R., and Woodle E.S. De novo breast cancer in renal transplant recipients. Transplant. Proc. 34 5 (2002) 1778-1779
-
(2002)
Transplant. Proc.
, vol.34
, Issue.5
, pp. 1778-1779
-
-
Buell, J.F.1
Hanaway, M.J.2
Trofe, J.3
Gross, T.G.4
Beebe, T.M.5
Alloway, R.R.6
First, M.R.7
Woodle, E.S.8
-
13
-
-
17844367860
-
De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population
-
Buell J.F., Papaconstantinou H.T., Skalow B., Hanaway M.J., Alloway R.R., and Woodle E.S. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant. Proc. 37 2 (2005) 960-961
-
(2005)
Transplant. Proc.
, vol.37
, Issue.2
, pp. 960-961
-
-
Buell, J.F.1
Papaconstantinou, H.T.2
Skalow, B.3
Hanaway, M.J.4
Alloway, R.R.5
Woodle, E.S.6
-
14
-
-
0032574187
-
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
-
Dantal J., Hourmant M., Cantarovich D., Giral M., Blancho G., Dreno B., and Soulillou J.P. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 351 9103 (1998) 623-628
-
(1998)
Lancet
, vol.351
, Issue.9103
, pp. 623-628
-
-
Dantal, J.1
Hourmant, M.2
Cantarovich, D.3
Giral, M.4
Blancho, G.5
Dreno, B.6
Soulillou, J.P.7
-
15
-
-
0033545299
-
Cyclosporine induces cancer progression by a cell-autonomous mechanism
-
Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., Shimbo T., and Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397 6719 (1999) 530-534
-
(1999)
Nature
, vol.397
, Issue.6719
, pp. 530-534
-
-
Hojo, M.1
Morimoto, T.2
Maluccio, M.3
Asano, T.4
Morimoto, K.5
Lagman, M.6
Shimbo, T.7
Suthanthiran, M.8
-
16
-
-
48649090163
-
Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer
-
Basu A., Contreras A.G., Datta D., Flynn E., Zeng L., Cohen H.T., Briscoe D.M., and Pal S. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res. 68 14 (2008) 5689-5698
-
(2008)
Cancer Res.
, vol.68
, Issue.14
, pp. 5689-5698
-
-
Basu, A.1
Contreras, A.G.2
Datta, D.3
Flynn, E.4
Zeng, L.5
Cohen, H.T.6
Briscoe, D.M.7
Pal, S.8
-
17
-
-
33744457937
-
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients
-
Opelz G., Naujokat C., Daniel V., Terness P., and Dohler B. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation 81 9 (2006) 1227-1233
-
(2006)
Transplantation
, vol.81
, Issue.9
, pp. 1227-1233
-
-
Opelz, G.1
Naujokat, C.2
Daniel, V.3
Terness, P.4
Dohler, B.5
-
18
-
-
2442668989
-
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
-
Koehl G.E., Andrassy J., Guba M., et al. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 77 9 (2004) 1319-1326
-
(2004)
Transplantation
, vol.77
, Issue.9
, pp. 1319-1326
-
-
Koehl, G.E.1
Andrassy, J.2
Guba, M.3
-
19
-
-
34250156366
-
The role of proliferation signal inhibitors in post-transplant malignancies
-
Gutierrez-Dalmau A., and Campistol J.M. The role of proliferation signal inhibitors in post-transplant malignancies. Nephrol. Dial. Transplant. 22 Suppl. 1 (2007) i11-i16
-
(2007)
Nephrol. Dial. Transplant.
, vol.22
, Issue.SUPPL. 1
-
-
Gutierrez-Dalmau, A.1
Campistol, J.M.2
-
20
-
-
34250183832
-
Use of proliferation signal inhibitors in the management of post-transplant malignancies-clinical guidance
-
Campistol J.M., Albanell J., Arns W., et al. Use of proliferation signal inhibitors in the management of post-transplant malignancies-clinical guidance. Nephrol. Dial Transplant. 22 Suppl. 1 (2007) i36-i41
-
(2007)
Nephrol. Dial Transplant.
, vol.22
, Issue.SUPPL. 1
-
-
Campistol, J.M.1
Albanell, J.2
Arns, W.3
-
21
-
-
20144367584
-
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
-
Stallone G., Schena A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N. Engl. J. Med. 352 13 (2005) 1317-1323
-
(2005)
N. Engl. J. Med.
, vol.352
, Issue.13
, pp. 1317-1323
-
-
Stallone, G.1
Schena, A.2
Infante, B.3
-
22
-
-
33746488875
-
Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?
-
Di Paolo S., Teutonico A., Leogrande D., Capobianco C., and Schena P.F. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?. J. Am. Soc. Nephrol. 17 8 (2006) 2236-2244
-
(2006)
J. Am. Soc. Nephrol.
, vol.17
, Issue.8
, pp. 2236-2244
-
-
Di Paolo, S.1
Teutonico, A.2
Leogrande, D.3
Capobianco, C.4
Schena, P.F.5
-
23
-
-
34147104488
-
AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells
-
Frost P., Shi Y., Hoang B., and Lichtenstein A. AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells. Oncogene 26 16 (2007) 2255-2262
-
(2007)
Oncogene
, vol.26
, Issue.16
, pp. 2255-2262
-
-
Frost, P.1
Shi, Y.2
Hoang, B.3
Lichtenstein, A.4
-
24
-
-
33847314632
-
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma
-
Di Paolo S., Teutonico A., Ranieri E., Gesualdo L., and Schena P.F. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. Am. J. Kidney Dis. 49 3 (2007) 462-470
-
(2007)
Am. J. Kidney Dis.
, vol.49
, Issue.3
, pp. 462-470
-
-
Di Paolo, S.1
Teutonico, A.2
Ranieri, E.3
Gesualdo, L.4
Schena, P.F.5
-
25
-
-
13944269599
-
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition
-
Goudar R.K., Shi Q., Hjelmeland M.D., et al. Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. Mol. Cancer Ther. 4 1 (2005) 101-112
-
(2005)
Mol. Cancer Ther.
, vol.4
, Issue.1
, pp. 101-112
-
-
Goudar, R.K.1
Shi, Q.2
Hjelmeland, M.D.3
-
26
-
-
10244229652
-
In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model
-
Frost P., Moatamed F., Hoang B., Shi Y., Gera J., Yan H., Gibbons J., and Lichtenstein A. In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model. Blood 104 13 (2004) 4181-4187
-
(2004)
Blood
, vol.104
, Issue.13
, pp. 4181-4187
-
-
Frost, P.1
Moatamed, F.2
Hoang, B.3
Shi, Y.4
Gera, J.5
Yan, H.6
Gibbons, J.7
Lichtenstein, A.8
-
27
-
-
27644436740
-
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
-
Kauffman H.M., Cherikh W.S., Cheng Y., Hanto D.W., and Kahan B.D. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80 7 (2005) 883-889
-
(2005)
Transplantation
, vol.80
, Issue.7
, pp. 883-889
-
-
Kauffman, H.M.1
Cherikh, W.S.2
Cheng, Y.3
Hanto, D.W.4
Kahan, B.D.5
-
28
-
-
33645458234
-
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
-
Campistol J.M., Eris J., Oberbauer R., et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J. Am. Soc. Nephrol. 17 2 (2006) 581-589
-
(2006)
J. Am. Soc. Nephrol.
, vol.17
, Issue.2
, pp. 581-589
-
-
Campistol, J.M.1
Eris, J.2
Oberbauer, R.3
-
29
-
-
34250156714
-
Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors
-
Pascual J. Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors. Nephrol. Dial Transplant. 22 Suppl. 1 (2007) i27-i35
-
(2007)
Nephrol. Dial Transplant.
, vol.22
, Issue.SUPPL. 1
-
-
Pascual, J.1
-
30
-
-
37349034394
-
Reduced exposure to calcineurin inhibitors in renal transplantation
-
Ekberg H., Tedesco-Silva H., Demirbas A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 357 25 (2007) 2562-2575
-
(2007)
N. Engl. J. Med.
, vol.357
, Issue.25
, pp. 2562-2575
-
-
Ekberg, H.1
Tedesco-Silva, H.2
Demirbas, A.3
-
31
-
-
0014433785
-
Immunologic rejection of human cancer transplanted with a renal allograft
-
Wilson R.E., Hager E.B., Hampers C.L., Corson J.M., Merrill J.P., and Murray J.E. Immunologic rejection of human cancer transplanted with a renal allograft. N. Engl. J. Med. 278 9 (1968) 479-483
-
(1968)
N. Engl. J. Med.
, vol.278
, Issue.9
, pp. 479-483
-
-
Wilson, R.E.1
Hager, E.B.2
Hampers, C.L.3
Corson, J.M.4
Merrill, J.P.5
Murray, J.E.6
-
32
-
-
0014702156
-
Transplanted carcinoma in an immunosuppressed patient
-
Matter B., Zukoski C.F., Killen D.A., and Ginn E. Transplanted carcinoma in an immunosuppressed patient. Transplantation 9 1 (1970) 71-74
-
(1970)
Transplantation
, vol.9
, Issue.1
, pp. 71-74
-
-
Matter, B.1
Zukoski, C.F.2
Killen, D.A.3
Ginn, E.4
-
33
-
-
23944489274
-
Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft
-
Morath C., Rohmeiss P., Schwenger V., et al. Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 80 4 (2005) 540-542
-
(2005)
Transplantation
, vol.80
, Issue.4
, pp. 540-542
-
-
Morath, C.1
Rohmeiss, P.2
Schwenger, V.3
-
34
-
-
0021349053
-
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
-
Starzl T.E., Nalesnik M.A., Porter K.A., et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1 8377 (1984) 583-587
-
(1984)
Lancet
, vol.1
, Issue.8377
, pp. 583-587
-
-
Starzl, T.E.1
Nalesnik, M.A.2
Porter, K.A.3
-
35
-
-
0023597816
-
Disseminated Kaposi's sarcoma-full regression after withdrawal of immunosuppressive therapy: report of a case
-
Wijnveen A.C., Persson H., Bjorck S., and Blohme I. Disseminated Kaposi's sarcoma-full regression after withdrawal of immunosuppressive therapy: report of a case. Transplant. Proc. 19 5 (1987) 3735-3736
-
(1987)
Transplant. Proc.
, vol.19
, Issue.5
, pp. 3735-3736
-
-
Wijnveen, A.C.1
Persson, H.2
Bjorck, S.3
Blohme, I.4
-
36
-
-
0036097712
-
Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression
-
Duman S., Toz H., Asci G., et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol. Dial Transplant. 17 5 (2002) 892-896
-
(2002)
Nephrol. Dial Transplant.
, vol.17
, Issue.5
, pp. 892-896
-
-
Duman, S.1
Toz, H.2
Asci, G.3
-
37
-
-
0037096705
-
Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine
-
Friedlaender M.M., Rubinger D., Rosenbaum E., Amir G., and Siguencia E. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 73 11 (2002) 1849-1850
-
(2002)
Transplantation
, vol.73
, Issue.11
, pp. 1849-1850
-
-
Friedlaender, M.M.1
Rubinger, D.2
Rosenbaum, E.3
Amir, G.4
Siguencia, E.5
-
38
-
-
0035051159
-
Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants
-
Otley C.C., Coldiron B.M., Stasko T., and Goldman G.D. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch. Dermatol. 137 4 (2001) 459-463
-
(2001)
Arch. Dermatol.
, vol.137
, Issue.4
, pp. 459-463
-
-
Otley, C.C.1
Coldiron, B.M.2
Stasko, T.3
Goldman, G.D.4
-
39
-
-
0029989141
-
Increasing transplant cancer patient survival by conversion of immunosuppressive agents
-
Chuang F.R., Hsieh H., Hsu K.T., and Huang H.F. Increasing transplant cancer patient survival by conversion of immunosuppressive agents. Transplant. Proc. 28 3 (1996) 1346-1347
-
(1996)
Transplant. Proc.
, vol.28
, Issue.3
, pp. 1346-1347
-
-
Chuang, F.R.1
Hsieh, H.2
Hsu, K.T.3
Huang, H.F.4
-
40
-
-
0024976004
-
Cyclosporine
-
Kahan B.D. Cyclosporine. N. Engl. J. Med. 321 25 (1989) 1725-1738
-
(1989)
N. Engl. J. Med.
, vol.321
, Issue.25
, pp. 1725-1738
-
-
Kahan, B.D.1
-
41
-
-
0029789453
-
Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection
-
Kahan B.D., Welsh M., Schoenberg L., Rutzky L.P., Katz S.M., Urbauer D.L., and Van Buren C.T. Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 62 5 (1996) 599-606
-
(1996)
Transplantation
, vol.62
, Issue.5
, pp. 599-606
-
-
Kahan, B.D.1
Welsh, M.2
Schoenberg, L.3
Rutzky, L.P.4
Katz, S.M.5
Urbauer, D.L.6
Van Buren, C.T.7
-
42
-
-
0036334289
-
Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month
-
Morris R.G., Russ G.R., Cervelli M.J., Juneja R., McDonald S.P., and Mathew T.H. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther. Drug Monit. 24 4 (2002) 479-486
-
(2002)
Ther. Drug Monit.
, vol.24
, Issue.4
, pp. 479-486
-
-
Morris, R.G.1
Russ, G.R.2
Cervelli, M.J.3
Juneja, R.4
McDonald, S.P.5
Mathew, T.H.6
-
43
-
-
0036150427
-
Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?
-
Oellerich M., and Armstrong V.W. Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?. Ther. Drug Monit. 24 1 (2002) 40-46
-
(2002)
Ther. Drug Monit.
, vol.24
, Issue.1
, pp. 40-46
-
-
Oellerich, M.1
Armstrong, V.W.2
-
44
-
-
0141768209
-
Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion
-
Thervet E., Pfeffer P., Scolari M.P., et al. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation 76 6 (2003) 903-908
-
(2003)
Transplantation
, vol.76
, Issue.6
, pp. 903-908
-
-
Thervet, E.1
Pfeffer, P.2
Scolari, M.P.3
-
45
-
-
0242300598
-
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
-
Midtvedt K., Fauchald P., Bergan S., et al. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?. Transplantation 76 8 (2003) 1236-1238
-
(2003)
Transplantation
, vol.76
, Issue.8
, pp. 1236-1238
-
-
Midtvedt, K.1
Fauchald, P.2
Bergan, S.3
-
46
-
-
0347917073
-
The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression
-
Einecke G., Mai I., Fritsche L., Slowinski T., Waiser J., Neumayer H.H., and Budde K. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression. Nephrol. Dial. Transplant. 19 1 (2004) 215-222
-
(2004)
Nephrol. Dial. Transplant.
, vol.19
, Issue.1
, pp. 215-222
-
-
Einecke, G.1
Mai, I.2
Fritsche, L.3
Slowinski, T.4
Waiser, J.5
Neumayer, H.H.6
Budde, K.7
-
47
-
-
33751531164
-
Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies
-
Sommerer C., Konstandin M., Dengler T., Schmidt J., Meuer S., Zeier M., and Giese T. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation 82 10 (2006) 1280-1285
-
(2006)
Transplantation
, vol.82
, Issue.10
, pp. 1280-1285
-
-
Sommerer, C.1
Konstandin, M.2
Dengler, T.3
Schmidt, J.4
Meuer, S.5
Zeier, M.6
Giese, T.7
-
48
-
-
0032846279
-
Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect
-
Stein C.M., Murray J.J., and Wood A.J. Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect. Clin. Chem. 45 9 (1999) 1477-1484
-
(1999)
Clin. Chem.
, vol.45
, Issue.9
, pp. 1477-1484
-
-
Stein, C.M.1
Murray, J.J.2
Wood, A.J.3
-
49
-
-
0036893274
-
Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression
-
Hartel C., Fricke L., Schumacher N., Kirchner H., and Muller-Steinhardt M. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression. Clin. Chem. 48 12 (2002) 2225-2231
-
(2002)
Clin. Chem.
, vol.48
, Issue.12
, pp. 2225-2231
-
-
Hartel, C.1
Fricke, L.2
Schumacher, N.3
Kirchner, H.4
Muller-Steinhardt, M.5
-
50
-
-
0033571210
-
The temporal profile of calcineurin inhibition by cyclosporine in vivo
-
Halloran P.F., Helms L.M., Kung L., and Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68 9 (1999) 1356-1361
-
(1999)
Transplantation
, vol.68
, Issue.9
, pp. 1356-1361
-
-
Halloran, P.F.1
Helms, L.M.2
Kung, L.3
Noujaim, J.4
-
51
-
-
40449093233
-
Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies
-
van Rossum H.H., Romijn F.P., Sellar K.J., Smit N.P., van der Boog P.J., de Fijter J.W., and van Pelt J. Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies. Clin. Chem. 54 3 (2008) 517-524
-
(2008)
Clin. Chem.
, vol.54
, Issue.3
, pp. 517-524
-
-
van Rossum, H.H.1
Romijn, F.P.2
Sellar, K.J.3
Smit, N.P.4
van der Boog, P.J.5
de Fijter, J.W.6
van Pelt, J.7
-
52
-
-
0034052928
-
Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP
-
Sottong P.R., Rosebrock J.A., Britz J.A., and Kramer T.R. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin. Diagn. Lab. Immunol. 7 2 (2000) 307-311
-
(2000)
Clin. Diagn. Lab. Immunol.
, vol.7
, Issue.2
, pp. 307-311
-
-
Sottong, P.R.1
Rosebrock, J.A.2
Britz, J.A.3
Kramer, T.R.4
-
53
-
-
34249990018
-
The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich
-
Wimmer C.D., Rentsch M., Crispin A., Illner W.D., Arbogast H., Graeb C., Jauch K.W., and Guba M. The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 71 12 (2007) 1271-1278
-
(2007)
Kidney Int.
, vol.71
, Issue.12
, pp. 1271-1278
-
-
Wimmer, C.D.1
Rentsch, M.2
Crispin, A.3
Illner, W.D.4
Arbogast, H.5
Graeb, C.6
Jauch, K.W.7
Guba, M.8
-
54
-
-
52649095428
-
Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients
-
Sommerer C., Hartschuh W., Enk A., Meuer S., Zeier M., and Giese T. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients. Clin. Transplant. 22 5 (2008) 549-554
-
(2008)
Clin. Transplant.
, vol.22
, Issue.5
, pp. 549-554
-
-
Sommerer, C.1
Hartschuh, W.2
Enk, A.3
Meuer, S.4
Zeier, M.5
Giese, T.6
-
55
-
-
38149059079
-
Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression
-
Sommerer C., Giese T., Schmidt J., Meuer S., and Zeier M. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Transplantation 85 1 (2008) 15-21
-
(2008)
Transplantation
, vol.85
, Issue.1
, pp. 15-21
-
-
Sommerer, C.1
Giese, T.2
Schmidt, J.3
Meuer, S.4
Zeier, M.5
-
56
-
-
67651167360
-
-
http://www.ctstransplant.org/.
-
-
-
|